2-氯-6-氟苯甲醚 | 53145-38-3

• 物质功能分类: 有机原料 - 有机氟化合物 - 氟苯甲醚系列
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-氯-6-氟苯甲醚
• 中文别名: 2-氟-6-氯苯甲醚；2-氯-6-氟苯甲醚, 97+%
• 英文名称: 1-chloro-3-fluoro-2-methoxybenzene
• 英文别名: 1-chloro-6-fluoroanisole；2-chloro-6-fluoroanisole；2,6-CFA；2-chloro-6-fluoro anisole
• CAS: 53145-38-3
• 化学式: C₇H₆ClFO
• mdl: MFCD01631573
• 分子量: 160.575
• InChiKey: QASFEHCRPLPGES-UHFFFAOYSA-N

物化性质

• 沸点：
  186.4±20.0 °C(Predicted)
• 密度：
  1.239±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于苯（微量）、可溶于氯仿、甲醇（微量）
• 保留指数：
  1054.2

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2909309090
• 包装等级：
  III
• WGK Germany：
  3
• 危险性防范说明：
  P305+P351+P338
• 危险性描述：
  H227,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Chloro-6-fluoroanisole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
H227: Combustible liquid
Keep away from heat/sparks/open flames/hot surfaces. No smoking
P210:
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Chloro-6-fluoroanisole
CAS number: 53145-38-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H6ClFO
Molecular weight: 160.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氯-6-氟苯甲醚 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 生成 2-氯-6-氟苯酚
  参考文献：
  名称：

  Piperazine- and piperidine-derivatives as melanocortin receptor agonists

  摘要：

  本发明涉及公式I的黑素皮质素受体激动剂，可用于治疗肥胖症、糖尿病以及男性和/或女性性功能障碍。

  公开号：

  US20040082590A1
• 作为产物：
  描述：

  2,3-二氯硝基苯 在 盐酸 、 1% platinum on charcoal 、 氢气 、 二异丙胺 作用下， 以 甲醇 、 水 、 甲苯 为溶剂， 60.0 ℃ 、450.01 kPa 条件下， 反应 26.5h， 生成 2-氯-6-氟苯甲醚
  参考文献：
  名称：

  一种2-氯-6-氟苯甲醚及其中间体的制备方法

  摘要：

  本发明公开了一种2-氯-6-氟苯甲醚及其中间体的制备方法。本发明公开的2-氯-6-氟苯甲醚的制备方法，包含下列步骤：在100～150℃的条件下，将如式V所示的化合物进行裂解反应。本发明公开的如式III所示的化合物的制备方法，包含下列步骤：溶剂中，在铂碳的催化下，将如式II所示的化合物与氢气进行还原反应，制得如式III所示的化合物。本发明公开的如式II所示的化合物的制备方法，包含下列步骤：溶剂中，在催化剂的作用下，将如式I所示的化合物与甲醇钠进行如下所示的醚化反应，制得如式II所示的化合物。本发明的制备方法原料廉价易得、生产成本低、反应条件温和、收率高以及更适用于工业化生产。

  公开号：

  CN103787846B

文献信息

• Estrogen receptor modulators
  申请人：——

  公开号：US20030027840A1

  公开（公告）日：2003-02-06

  The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a variety of conditions related to estrogen functioning including: bone loss, bone fractures, osteoporosis, cartilage degeneration, endometriosis, uterine fibroid disease, hot flashes, increased levels of LDL cholesterol, cardiovascular disease, impairment of cognitive functioning, cerebral degenerative disorders, restinosis, gynacomastia, vascular smooth muscle cell proliferation, obesity, incontinence, and cancer, in particular of the breast, uterus and prostate.

  本发明涉及化合物及其衍生物、它们的合成方法以及它们作为雌激素受体调节剂的应用。本发明的化合物是雌激素受体的配体，因此可用于治疗或预防与雌激素功能相关的多种疾病，包括：骨丢失、骨折、骨质疏松症、软骨退化、子宫内膜异位症、子宫纤维瘤病、热潮红、LDL胆固醇水平升高、心血管疾病、认知功能损害、脑部退行性疾病、再狭窄、男性乳房发育、血管平滑肌细胞增殖、肥胖、失禁以及癌症，尤其是乳腺癌、子宫癌和前列腺癌。
• NOVEL SUBSTITUTED TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
  申请人：Van Brandt Sven Franciscus Anna

  公开号：US20120295891A1

  公开（公告）日：2012-11-22

  The present invention is concerned with novel substituted triazole derivatives of Formula (I) wherein Het 1 , R 1 , R 2 , A 1 , A 2 , A 3 , A 4 , L 1 , and L 2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及具有以下式（I）的新型取代三唑衍生物，其中Het1，R1，R2，A1，A2，A3，A4，L1和L2的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。本发明还涉及制备这种新型化合物的方法，包括将所述化合物作为活性成分的药物组合物以及将所述化合物用作药物的用途。
• Synthesis of a selective estrogen receptor β-modulator via asymmetric phase-transfer catalysis
  作者：Mark A. Huffman、Jonathan D. Rosen、Roger N. Farr、Joseph E. Lynch

  DOI：10.1016/j.tet.2007.03.074

  日期：2007.5

  efficient asymmetric synthesis of selective estrogen receptor β-modulator (S)-4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-fluoren-3-one was developed. The route features a chemoselective aromatic chlorination reaction, an asymmetric phase-transfer-catalyzed alkylation of an indanone with efficient ee upgrade by racemate crystallization, and a robust bromination reaction using imidazole

  选择性雌激素受体β-调节剂（S）-4-溴-9a-丁基-8-氯-6-氟-7-羟基-1,2,9,9a-四氢-芴-3-酮的有效不对称合成发展了。该路线的特点是化学选择性的芳族氯化反应，茚满酮的不对称相转移催化的烷基化以及通过外消旋体结晶的有效ee升级，以及使用咪唑作为原位溴阱的稳健溴化反应，以避免过度反应。由2-氟茴香醚在8个步骤中以34％的产率进行合成，并提供具有> 99.5％ee的材料。
• METHODS FOR PRODUCING BORYLATED ARENES
  申请人：Dow AgroSciences, LLC

  公开号：US20150065743A1

  公开（公告）日：2015-03-05

  Methods for the selective borylation of arenes, including arenes substituted with an electron-withdrawing group (e.g., 1-chloro-3-fluoro-2-substituted benzenes) are provided. The methods can be used, in some embodiments, to efficiently and regioselectively prepare borylated arenes without the need for expensive cryogenic reaction conditions.

  提供了一种选择性硼化芳烃的方法，包括带有电子吸引基团的芳烃（例如，1-氯-3-氟-2-取代苯）。在某些实施方式中，这些方法可以用来高效和区域选择性地制备硼化芳烃，而无需昂贵的低温反应条件。
• PROCESS FOR THE PREPARATION OF 6-(ARYL)-4-AMINOPICOLINATES
  申请人：Renga James M.

  公开号：US20100311981A1

  公开（公告）日：2010-12-09

  3-Halo-6-(aryl)-4-iminotetrahydropicolinic acid esters are heated with polar solvents to prepare 6-(aryl)-4-aminopicolinates.

  3-卤代-6-(芳基)-4-亚胺四氢吡啶甲酸酯在极性溶剂中加热，可制备6-(芳基)-4-氨基吡啶酸酯。